Letrozole 2.5Mg Tablet

DRUG5 trials

Sponsors

Instituto Nacional de Cancer, Brazil, Guangdong Provincial People's Hospital, Mansoura University, Menoufia University, Beni-Suef University

Conditions

Breast NeoplasmEMBRYO IMPLANTATIONHighly Endocrine Responsive Operable Breast CancerInduction of OvulationOvarian Stimulation

Phase 2

A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

Instituto Nacional de Cancer, BrazilBreast Neoplasm

Start: 2017-03-06End: 2020-09-30Target: 20Updated: 2019-08-15

Neoadjuvant Endocrine Therapy in Breast Cancer

CompletedNCT03397537

Guangdong Provincial People's HospitalHighly Endocrine Responsive Operable Breast Cancer

Start: 2012-09-30End: 2017-07-31Updated: 2018-01-17

Phase 4

The Outcomes of ICSI Cycles With and Without Letrozole

Mansoura UniversityEMBRYO IMPLANTATION

Start: 2019-12-01End: 2020-12-30Target: 224Updated: 2019-12-16

Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation

CompletedNCT07589075

Beni-Suef UniversityInduction of Ovulation

Start: 2023-10-20End: 2025-10-30Updated: 2026-05-15

Unknown Phase

Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle

CompletedNCT05166668

Menoufia UniversityOvarian Stimulation

Start: 2021-11-01End: 2025-02-10Updated: 2025-02-12

Related Papers

36P Megestrol acetate resistance in estrogen receptor-positive advanced breast cancer in the MEGA trial

ESMO Open2023-05-01